When was Kremers Urban Pharmaceuticals founded?

Kremers Urban Pharmaceuticals was founded in 1904.

Where is Kremers Urban Pharmaceuticals located?

Kremers Urban Pharmaceuticals is headquartered in Seymour, United States.

How many employees does Kremers Urban Pharmaceuticals have?

As of Sep 30, 2026, the latest employee count at Kremers Urban Pharmaceuticals is 81.

Where does Kremers Urban Pharmaceuticals rank among its competitors?

Kremers Urban Pharmaceuticals ranks 680th amongst 1245 active competitors, of which 43 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Kremers Urban Pharmaceuticals?

Kremers Urban Pharmaceuticals' top competitors include Bayer, Teva Pharmaceuticals and Wockhardt. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Kremers Urban Pharmaceuticals - 2026 Company Profile, Funding & Competitors

Company Details

Generic pharmaceutical manufacturer providing affordable medicines with a patient-first philosophy. The company develops, manufactures, and markets a wide range of generic pharmaceutical products across various therapeutic areas. They focus on high-quality standards and strive to make medicines accessible to patients who depend on them. Their capabilities include product development, regulatory affairs, and supply chain management. They also offer contract development and manufacturing organization (CDMO) services. The company emphasizes innovation and is committed to enhancing lives through its pharmaceutical offerings. They are dedicated to safe medication disposal and patient support.

Website: kremersurban.com
Part Of

Key Metrics

Founded Year

1904

Location

Seymour, United States

Stage

Acquired

Investors

Advent International

Ranked

680^th among 1245 active competitors

Employee Count

81 as on Sep 30, 2026

Similar Companies

Teva Pharmaceuticals & 1462 more

Exit Details

Acquired by Lannett (Sep 02, 2015)

View Kremers Urban Pharmaceuticals' full profile

Kremers Urban Pharmaceuticals got acquired by Lannett on Sep 02, 2015 at an acquisition amount of $*****.

Click here to take a look at Kremers Urban Pharmaceuticals's acquisition in detail

Kremers Urban Pharmaceuticals is a funded company. Kremers Urban Pharmaceuticals has 1 institutional investor.

View details of Kremers Urban Pharmaceuticals's funding rounds and investors

Kremers Urban Pharmaceuticals' employee count trend

Kremers Urban Pharmaceuticals has 81 employees as of Sep 26. Here is Kremers Urban Pharmaceuticals's employee count trend over the years:

Employee count trend for Kremers Urban Pharmaceuticals

Uncover Kremers Urban Pharmaceuticals' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kremers Urban Pharmaceuticals include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Kremers Urban Pharmaceuticals, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Lupin 1968, Mumbai (India), Public	Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients	$6.64M	Cipher International, AbbVie & 5 others	71/100
5th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
6th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
7th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
8th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
9th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
10th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
680th	Kremers Urban Pharmaceuticals 1904, Seymour (United States), Acquired	Generic pharmaceutical manufacturer providing affordable medicines with a patient-first philosophy	-	Advent International	29/100